Garivulimab [2342597-81-1]

TargetMol Chemicals

Garivulimab

9

2342597-81-1

Antibody

Research Use Only

Garivulimab

Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1, thereby selectively inhibiting the PD-L1/PD-1 interaction, which confers its antitumor activity [1].

3 years

-20°C

12352203